RecruitingNAINTERVENTIONAL

Impact of Training Patient-centered Approach on Shared Decision in Colorectal Cancer Screening

This study is investigating whether giving GPs special training in a 'patient-centred approach' can encourage more people to take part in bowel cancer screening. Bowel cancer screening is important, but not enough people are currently taking part in France, where this study is taking place. The research will compare how many patients get screened when their doctor has received this communication training, versus those whose doctor has not. The training helps doctors talk to patients more effectively about screening, addressing any worries and working together to make decisions. The study hopes to find out if this improved way of talking can overcome common reasons why people might avoid screening, ultimately leading to better health outcomes.

At a glance

Status

Recruiting

Phase

Sponsor

CNGE Conseil

Enrolment target

400

Start

06 Mar 2024

Estimated completion

30 Nov 2027

Colorectal Cancer Screening

What is this study about?

This study is looking into a really important question: how can we encourage more people to take part in bowel cancer (colorectal cancer) screening? Bowel cancer is a serious illness, and finding it early through screening can make a big difference to treatment success. In France, screening involves a simple test done at home every two years for people aged 50 to 74. However, it seems that many people aren't taking part, even though widespread screening could save lives.

The researchers think that the way doctors talk to their patients about screening might play a big part. Some people might be put off by the idea of the test or have worries about what might happen if cancer is found. Doctors themselves might find it tricky to bring up the subject. This study is testing if giving doctors special training in a 'patient-centred approach' can help. This means learning to listen carefully to patients' concerns, explaining things clearly, and making decisions together.

So, the study will compare two groups of doctors. One group will get this special training, and the other will continue as usual. The researchers will then see if patients whose doctors had the training are more likely to take part in bowel cancer screening. The goal is to find better ways for doctors and patients to talk about important health checks, leading to more people getting screened and potentially catching bowel cancer at an earlier, more treatable stage.

Key takeaways

The study helps doctors communicate better about bowel cancer screening.
It aims to increase the number of people taking part in life-saving screening.
Participation mainly involves your doctor's communication style, not new treatments.
If eligible, you'd be between 50 and 74 years old.
Early detection of bowel cancer through screening can improve treatment outcomes.

Who may be eligible?

To be able to join this study, you would need to be between 50 and 74 years old. You also need to be eligible for the standard bowel cancer screening programme in France and see a GP who is involved in this study. You should also be able to understand and follow the study's instructions.

There are several reasons why you might not be able to join. For example, if you've already been screened for bowel cancer in the last two years, or if you have a history of certain bowel conditions like Crohn's disease, ulcerative colitis, or specific types of polyps or bowel cancer in your family or yourself. If you have any symptoms that would already mean you need a colonoscopy, you wouldn't be able to join. Also, if you have difficulty reading or understanding questionnaires, or are unable to give your agreement to be part of the study, you wouldn't be eligible.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

Are you between 50 and 74 years old?
Are you eligible for regular bowel cancer screening?
Is your GP involved in this research study?
Have you NOT had bowel cancer screening in the last two years?
Do you NOT have a personal or family history of certain serious bowel conditions?

Answer every question to see your result.

What does participation involve?

The description for this study doesn't go into detail about what taking part involves for individual patients beyond seeing your doctor. It focuses more on the training for the doctors. However, if you are eligible and your GP is part of the study, you might be asked to fill out a questionnaire to help the researchers understand more about your views and experiences with screening. The main point of the study for patients is whether they decide to take part in the standard bowel cancer screening when offered by their GP. There is no mention of extra clinic visits, new medications, or specific follow-up beyond what is typical for standard screening.

Potential risks and benefits

The main benefit of taking part in this study is the potential for your doctor to have improved communication skills, which could make discussing bowel cancer screening easier and more reassuring for you. This might encourage you to participate in screening, which can lead to early detection of bowel cancer, improving chances of successful treatment. For the study itself, there are no specific medical risks mentioned for patients, as the main intervention is training for doctors. You always have the right to withdraw from the study at any time without affecting your usual medical care.

Locations (1)

Cabinet de groupe pluriprofessionnel
Verified postcode
Soisy-sous-Montmorency, France· Recruiting

Common questions

What is bowel cancer screening?

It's a test to check for early signs of bowel cancer in people who don't have any symptoms, helping to catch it when it's easier to treat.

What is a 'patient-centred approach'?

It's a way for doctors to talk to patients where they really listen to your worries and wishes, and make decisions together with you.

Why is this study important?

It aims to find better ways to help more people get screened for bowel cancer, which could save lives by finding cancer earlier.

Will I have to take new medicines if I join?

No, this study is about how doctors talk to patients, not about giving new medicines.

Who is running this study?

This study is being run by researchers in France, focusing on their national bowel cancer screening programme.

How to find out more

Isabelle AUGER-AUBIN, Pr

isabelle.auger-aubin@u-paris.fr 06 83 28 26 36 Official trial record

Always speak to your GP or specialist before deciding to take part in a study.